Submit a Manuscript to the Journal
Cancer Biology & Therapy
For an Article Collection on
Radioligand Therapy for Cancer
Manuscript deadline
Article collection guest advisor(s)
Dr. Scott Waldman,
Thomas Jefferson University Sidney Kimmel Cancer Center
Dr. Jonathan R. Brody,
Oregon Health and Science University
Radioligand Therapy for Cancer
Cancer Biology & Therapy is pleased to announce an upcoming Article Collection dedicated to the emerging field of radioligand therapy (RLT) for cancer.
RLT is an innovative cancer treatment that combines a targeting molecule – the ligand – with a radioisotope to deliver precise doses of radiation directly to cancer cells, aiming to destroy cancer cells or cells in the tumor microenvironment while minimizing damage to surrounding healthy tissue.
This therapeutic approach has the potential to improve outcomes for patients with difficult-to-treat cancers. By combining the specificity of targeted therapy with the efficacy of radiation, RLT offers a new avenue for personalized cancer treatment.
However, widespread use of and access to RLT is hindered by the complex logistics of producing and delivering these therapies, including the need for specialized hospital facilities, a workforce trained in nuclear medicine, and the radioactivity and short shelf life of radioligands.
We welcome papers that highlight the latest advancements in RLT, including basic science, translational research, and clinical applications.
***
This Article Collection will be included in a wider Game Changer Series focused on breakthrough therapies across medicine. Papers published within the Game Changer series will benefit from additional promotional activities across Taylor and Francis, increasing the discoverability and visibility of your research.
Submitting authors are eligible for a 20% discount on the Article Publishing Charge. To apply this discount, enter the code KCBT-2026-C36121 when prompted during submission.
Please contact Commissioning Editor Cassie Houtz at cassie.houtz@taylorandfrancis.com with any questions.
Benefits of publishing open access within Taylor & Francis
Global marketing and publicity, ensuring your research reaches the people you want it to.
Article Collections bring together the latest research on hot topics from influential researchers across the globe.
Rigorous peer review for every open access article.
Rapid online publication allowing you to share your work quickly.
Submission Instructions
All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Guest Advisors for this collection will not be involved in peer-reviewing manuscripts unless they are an existing member of the Editorial Board. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.